Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CVS HEALTH Corp Director's Dealing 2010

Feb 1, 2010

29875_dirs_2010-02-01_9777128c-ee9b-4bd5-afdf-b1d2d78cb6be.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: CVS CAREMARK CORP (CVS)
CIK: 0000064803
Period of Report: 2010-02-01

Reporting Person: Finley Sara (SVP, Gen Counsel)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 7692 Direct
Common Stock (restricted) 3441 Direct
Common Stock (restricted) 7287 Direct
Common Stock (restricted) 4449 Direct
Common Stock (restricted) 21860 Direct
Common Stock (restricted) 8965 Direct
Common Stock (restricted) 3644 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option $20.23 2015-03-01 Common Stock (183165) Direct
Stock Option $27.12 2016-03-01 Common Stock (131158) Direct
Stock Option $34.42 2014-04-02 Common Stock (125250) Direct
Stock Option $41.17 2015-04-01 Common Stock (51892) Direct
Stock Option $28.10 2016-04-01 Common Stock (53531) Direct

Footnotes

F1: Includes shares acquired through the participation in the Issuer's Employee Stock Purchase Plan.

F2: Consists of Restricted Stock Units awarded pursuant to Issuer's 1997 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing 2/18/2010.

F3: Consists of Restricted Stock Units awarded pursuant to Issuer's 1997 Incentive Compensation Plan. Restrictions lapse 4/1/2012.

F4: Consists of Restricted Stock Units awarded pursuant to Issuer's 1997 Incentive Compensation Plan. Restrictions lapse 4/1/2013.

F5: Consists of Restricted Stock Units awarded pursuant to Issuer's 1997 Incentive Compensation Plan. Restrictions lapse 3/22/2010.

F6: Consists of Restricted Stock Units awarded at market price pursuant to Issuer's 1997 Incentive Compensation Plan, the receipt of which the reporting person has elected to defer.

F7: Consists of Restricted Stock Units awarded pursuant to Issuer's 1997 Incentive Compensation Plan. Restrictions lapse 4/1/2012.

F8: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS Caremark Corporation stock option. Option is 100% exercisable as of the date of merger.

F9: Option became exercisable in three equal annual installments on 4/2/2008.

F10: Option became exercisable in three equal annual installments on 4/1/2009.

F11: Option becomes exercisable in three equal annual installments, commencing 4/1/2010.